Source: Supplementary table 3, Supplementary figure 1
Description: A detailed analysis of the MGSs that differed significantly between treatment groups
Abundance in Group 1: decreased abundance
in
moxifloxacin treated group (MXF)
NCBI | Quality Control | Links |
---|
Alistipes | | |
Alistipes finegoldii | | |
Alistipes onderdonkii | | |
Alistipes putredinis | | |
Alistipes shahii | | |
Bacteroidales | | |
Barnesiella intestinihominis | | |
Bifidobacterium adolescentis | | |
Bifidobacterium pseudocatenulatum | | |
Bilophila wadsworthia | | |
Blautia | | |
Blautia sp. | | |
Butyricimonas | | |
Butyricimonas virosa | | |
Catenibacterium | | |
Cloacibacterium sp. | | |
Clostridium | | |
Clostridium sp. | | |
Coprobacillus | | |
Dorea formicigenerans | | |
Eubacteriales | | |
Eubacterium | | |
Faecalibacterium | | |
Faecalibacterium prausnitzii | | |
Bacillota | | |
Haemophilus parainfluenzae | | |
Intestinibacter bartlettii | | |
Lachnospira eligens | | |
Lachnospiraceae | | |
Odoribacter splanchnicus | | |
Oscillibacter | | |
Oscillibacter sp. | | |
Oscillospiraceae | | |
Parabacteroides distasonis | | |
Parasutterella excrementihominis | | |
Roseburia inulinivorans | | |
Ruminococcus callidus | | |
Streptococcus parasanguinis | | |
Revision editor(s): Lwaldron,
WikiWorks